The world’s premier life sciences event returns to Philadelphia for
four days of inspiring keynote speeches, fireside chats and educational
programming

PHILADELPHIA–(BUSINESS WIRE)–The 2019
BIO International Convention
today welcomes more than 16,000
attendees and 1,800 exhibitors from 67 countries to the world’s premier
life sciences event. This year’s Convention includes 18 educational
tracks, covering all sectors of biotechnology including gene therapy,
personalized medicine, digital health, regulatory innovation and more.

“The world’s biotechnology ecosystem is gathered here in Philadelphia
for a week of enriching programming, thought-provoking conversations and
unlimited networking opportunities,” said Jim Greenwood, President and
CEO of the Biotechnology Innovation Organization (BIO). “We know that it
takes just one meeting, one partnership or one idea to spark
life-changing advances in biotech. We believe that many of these
important moments will happen this week at the BIO Convention.”

Convention Highlights Include:

  • Keynote: Siddhartha
    Mukherjee, Pulitzer Prize-winning author, physician and oncologist

    Tuesday,
    June 4, 9:00–10:30 am | Ballroom AB

    • Siddhartha Mukherjee will be interviewed by BIO President and CEO
      Jim Greenwood about the unique challenges and opportunities for
      the biotech community in developing cures for cancer and genetic
      diseases.
    • PLEASE NOTE: Keynotes are open to Convention Access and
      Partnering Attendees. Seating is first-come, first-served.
  • Keynote: Jamie
    Dimon, Chairman and CEO of JPMorgan Chase

    Wednesday,
    June 5, 9:00–10:45 am | Ballroom AB

    • Jamie Dimon will be interviewed by BIO President and CEO Jim
      Greenwood on strategies and actionable steps for improving
      employee satisfaction and cultivating a diverse and inclusive
      workplace.
    • PLEASE NOTE: Keynotes are open to Convention Access and
      Partnering Attendees. Filming is not permitted. Seating is
      first-come, first-served.
  • Super Session: Realizing
    the Promise of Gene Therapies for Patients Around the World

    Tuesday,
    June 4, 2:30-3:45 pm | 103ABC, Level 1

    Gene therapies are
    transforming patients’ lives in ways that were unimaginable twenty
    years ago. With recent scientific advances, commercial gene therapies
    have been met with exciting opportunities for treatment for previously
    untreatable genetic diseases. With these advances come challenges and
    opportunities in scientific discovery and new approaches in delivering
    drugs. Attend this Super Session to gain insights and perspectives
    from stakeholders with experience tackling these challenges while
    bringing new types of treatments to patients.
  • Fireside Chat: Christi
    Shaw, Senior Vice President and President, Lilly BIO-Medicines, Eli
    Lilly and Company

    Tuesday, June 4, 2:00-3:00 pm |
    108A, Level 100

    For Christi Shaw, “More moments for more
    memories” isn’t just a mantra – it’s a personal and professional
    mission. She leads through the lens of innovation, integrity and
    inclusion and brings an unwavering commitment to addressing the
    evolving needs of patients, in collaboration with healthcare
    professionals, advocacy groups, payers and policy makers.
  • Fireside Chat: Jeremy
    Levin, CEO, Chairman at Ovid Therapeutics interviews Jeffrey Solomon,
    Chief Executive Officer at COWEN

    Tuesday, June 4,
    11:00 am – 12:00 pm
    | 108A, Level 100
    A
    conversation with Jeffrey Solomon, former President, Chief Operating
    Officer and Head of Investment Banking at COWEN, a global financial
    services firm. Currently, Solomon is also a Director of NuGo
    Nutrition, the manufacturer of NuGo Nutrition Bars. Solomon is
    co-chair of the Equity Capital Formation Task Force, a group of
    individuals from across the country’s startup and small-capitalization
    company ecosystems advocating for market structure reform to encourage
    job creation and growth.
  • Fireside Chat: Kenneth
    C. Frazier, Chairman of the Board and Chief Executive Officer, Merck &
    Co., Inc.

    Wednesday, June 5, 11:00-11:45 am | 103ABC,
    Level 100

    During his fireside chat, Kenneth Frazier will
    discuss how Merck is delivering innovative, lifesaving medicines and
    vaccines as well as long-term and sustainable value to its
    stakeholders.

Monday, June 3, Highlights Include:

  • Fireside Chat: Margaret
    (Peggy) Hamburg, MD, Foreign Secretary, National Academy of Medicine;
    Chairman of the Board, American Association for the Advancement of
    Science

    2:30-3:45 pm | 115A, Level 100
    Dr.
    Hamburg is an internationally recognized leader in public health and
    medicine. As Foreign Secretary of the National Academy of Medicine,
    she serves as senior advisor on international matters and liaison with
    other Academies of Medicine around the world. She is also the Chairman
    of the Board/Past-President of the American Association for the
    Advancement of Science (AAAS), the world’s largest scientific
    membership organization.
  • Super Session: What’s
    Next: The Landscape of Innovation in 2019 and Beyond

    3:00-4:30
    pm | 103ABC, Level 100

    In this session, biotechnology
    leaders will highlight emerging clusters of innovation attracting
    capital and the key therapeutic targets and novel mechanistic
    approaches with the potential to drive value creation in the future.
    Speakers will also examine how market forces and overall value in
    therapeutic areas may drive investment decisions in R&D and M&A, both
    today and into the future.
  • BioGENEius: Posters
    Open and Challenge Judging

    9:00 am – 3:00 pm | 108AB
    Foyer

    The BioGENEius Challenges are an annual
    biotechnology research competition that involves more than 2,000 high
    schools, thousands of biology teachers, over 7,000 students and 15
    state and international. Winners are announced each year at the BIO
    International Convention before thousands of the world’s biotechnology
    leaders. The BioGENEius program not only provides an opportunity to
    encourage young students to fill the ever-growing demand for biotech
    scientists and entrepreneurs but showcases the industry’s commitment
    to BIO’s goals of healing, feeding and fueling the world.
  • Company
    Presentations in the Business Forum

    1:30-5:30 pm |
    Theaters 1-4

    Participating companies will deliver
    13-minute presentations on company story, pipelines and objectives to
    a global audience of business development executives, investors,
    research analysts, policy makers and media, representing more than 70
    countries.

Follow the 2019 Convention @BIOConvention
and join the conversation @IAmBIOtech.

About BIO

BIO is the world’s largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention
, the world’s largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW is
BIO’s blog chronicling “innovations transforming our world” and the BIO
Newsletter is the organization’s bi-weekly email newsletter. Subscribe
to the BIO Newsletter
.

Contacts

Biotechnology Innovation Organization (BIO)
Theresa
Brady

202-962-9235
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech